Invasight
Invasight is a clinical biotech company that focused on revolutionizing cell invasion research.
Operating in biopharma, biotechnology, health care based in Europe, Middle East, and Africa (EMEA), Invasight was founded in 2019.
Its activity falls under biopharma, biotechnology, health care; the profile below is assembled from public directory data.
The company is recorded as being based in Europe, Middle East, and Africa (EMEA).
It is recorded at the Seed stage.
Recorded headcount: c_00001_00010 employees.
Public records show total funding of about $4.6M.
| Sector | Biopharma, Biotechnology, Health Care |
|---|---|
| Headquarters | Europe, Middle East, and Africa (EMEA) |
| Founded | 2019 |
| Employees | c_00001_00010 |
| Stage | seed |
| Total funding | $4,590,000 |
Website: www.invasight.com
Contact details and direct channels are available to signed-in members.
Create a free account
Create a free account